PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: Investor Presentation - $66m Capital Raise, page-65

  1. 146 Posts.
    lightbulb Created with Sketch. 21
    Fully agree, exactly the same concern i raised as well about the DMOAD attempt potentially meaning the FDA making us wait until DMOAD is shown (rather than just pain relief) before we can get approval
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 24.0¢ 22.5¢ $186.1K 801.8K

Buyers (Bids)

No. Vol. Price($)
4 33599 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 65498 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.